Mortality of Cancer Surgery During SARS CoV2 Pandemic
Preoperative Screening for COVID-19 and Strict COVID Cancer Protocol Helps to Reduce Postoperative Infection, Mortality and Morbidity in Cancer Patients Undergoing Surgery. A Comparative Study
1 other identifier
observational
1,576
1 country
1
Brief Summary
The impact of cancer surgery during covid epidemic is not clear. The published reports show contradictory findings that extend from no change in mortality to increased mortality, further no data on exposure and outcome of health care worker is available. This study is designed to address the above questions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2022
CompletedFirst Submitted
Initial submission to the registry
February 12, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedMarch 3, 2022
February 1, 2022
2 months
February 12, 2022
February 15, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
30 day mortality
post operative deaths within one year
30 days
number of participants developing major or minor complications
Surgical complications classified as per Clavien Dindo classification
30 days
Secondary Outcomes (1)
number of health care worker with SARS CoV2 infection
1 year
Study Arms (2)
Pre covid
Cases operated one year prior to the date of declaration of corona pandemic in India
post covid
cases operated from the date of declaration of corona pandemic to one year after
Interventions
Eligibility Criteria
All cases of cancer operated between April 2019 to May 2021
You may qualify if:
- All patients operated during the study period
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Banaras Hindu University
Varanasi, Uttar Pradesh, 221005, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manoj Pandey, MS, PhD
Banaras Hindu University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 12, 2022
First Posted
February 15, 2022
Study Start
October 29, 2021
Primary Completion
December 31, 2021
Study Completion
January 15, 2022
Last Updated
March 3, 2022
Record last verified: 2022-02